Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Schaefer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancerRamaswamy Govindan, Daniel Morgensztern, Michael D Kommor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigationShauna L Hillman, Ming-Wen An, Michael J O'Connell, et al.
Cancer|January 7, 2010
Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803Nadine Jackson McCleary, Donna Niedzwiecki, Donna Hollis, et al.
Journal of Neuro-Oncology|April 14, 2007
Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic gradeJan C Buckner, Judith R O'Fallon, Robert P Dinapoli, et al.
Breast Cancer Research and Treatment|August 2, 2003
A phase II study of topical ceramides for cutaneous breast cancerAminah Jatoi, Vera J Suman, Paul Schaefer, et al.
Pancreas|October 18, 2016
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway ApproachJames J Farrell, Jennifer Moughan, Jonathan L Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803Shuji Ogino, Jeffrey A Meyerhardt, Natsumi Irahara, et al.
JAMA|June 5, 2008
Association of family history with cancer recurrence and survival among patients with stage III colon cancerJennifer A Chan, Jeffrey A Meyerhardt, Donna Niedzwiecki, et al.
JAMA|March 6, 2008
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trialWilliam F Regine, Kathryn A Winter, Ross A Abrams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803Shuji Ogino, Kaori Shima, Jeffrey A Meyerhardt, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancerRamaswamy Govindan, Daniel Morgensztern, Michael D Kommor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigationShauna L Hillman, Ming-Wen An, Michael J O'Connell, et al.
Cancer|January 7, 2010
Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803Nadine Jackson McCleary, Donna Niedzwiecki, Donna Hollis, et al.
Journal of Neuro-Oncology|April 14, 2007
Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic gradeJan C Buckner, Judith R O'Fallon, Robert P Dinapoli, et al.
Breast Cancer Research and Treatment|August 2, 2003
A phase II study of topical ceramides for cutaneous breast cancerAminah Jatoi, Vera J Suman, Paul Schaefer, et al.
Pancreas|October 18, 2016
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway ApproachJames J Farrell, Jennifer Moughan, Jonathan L Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803Shuji Ogino, Jeffrey A Meyerhardt, Natsumi Irahara, et al.
JAMA|June 5, 2008
Association of family history with cancer recurrence and survival among patients with stage III colon cancerJennifer A Chan, Jeffrey A Meyerhardt, Donna Niedzwiecki, et al.
JAMA|March 6, 2008
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trialWilliam F Regine, Kathryn A Winter, Ross A Abrams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803Shuji Ogino, Kaori Shima, Jeffrey A Meyerhardt, et al.
Pageof 3